デフォルト表紙
市場調査レポート
商品コード
1680761

頭頸部がん診断の世界市場レポート:動向、予測、競合分析(~2031年)

Head and Neck Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2031


出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

頭頸部がん診断の世界市場レポート:動向、予測、競合分析(~2031年)
出版日: 2025年03月13日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の頭頸部がん診断市場の将来は、病院、外来手術センター、診断センター市場に機会があり、有望です。世界の頭頸部がん診断の市場規模は、2025年~2031年のCAGRが7.1%で、2031年までに推定34億米ドルに達すると予想されています。この市場の主な促進要因は、頭頸部がんの有病率の増加、ヘルスケアへのアクセスの向上、頭頸部がんの徴候や症状、早期発見の重要性に対する意識の高まりです。

  • Lucintelの予測では、診断別では、画像診断が予測期間中に最も高い成長を遂げる見込みです。
  • 最終用途別では、病院はより優れた疾病診断能力を持ち、また最新の医療機器と技術を備えており、患者に最善の治療を提供することができるため、病院が引き続き最大のセグメントとなると思われます。
  • 地域別では、北米は強力なヘルスケアインフラの存在、有利な償還政策、疾患に関する高い認知度、ヘルスケアセクターの開発に対する政府の支援により、予測期間中最大の地域であり続けると思われます。

頭頸部がん診断市場の戦略的成長機会

頭頸部がん診断市場は、複数の用途にまたがる様々な成長機会を提供しています。これらの機会を理解することで、利害関係者は投資・開発分野を選択することができます。

  • 分子診断:分子診断検査に対する需要の高まりは、市場に大きな機会をもたらしています。これらの検査は頭頸部がんの早期発見と分類を可能にし、効果的な治療に必要な重要な情報を提供します。
  • AI強化画像ソリューション:ヘルスケア専門家は、診断精度を向上させるAI強化画像ソリューションを必要としています。これらの技術は高い潜在能力を秘めており、診断効率と患者管理を強化するために開発・市場開拓が可能です。
  • リキッドバイオプシー用途:リキッドバイオプシー(液体生検)用途の利用拡大は収益成長を促進します。早期診断や治療評価のための非侵襲的検査が急速に台頭しており、患者とサービス提供者の双方に利益をもたらします。
  • 遠隔医療との統合:遠隔医療の統合は、診断サービスを遠隔で提供することにより、本格的な成長機会を提供します。遠隔診断ツールの市場を拡大することで、特に遠隔地における患者ケアを改善することができます。
  • 共同研究への取り組み:学術研究機関と臨床研究機関のコラボレーションは、市場性のある診断ツールや技術の迅速な開発につながります。このようなイニシアチブは、企業が市場競争力を高めるのに役立ちます。

こうした戦略的成長機会は、頭頸部がん診断市場における新たなギャップに対処するものであり、利害関係者は患者管理と市場競争を強化する革新的ソリューションを育成することができます。

頭頸部がん診断市場の促進要因・課題

市場促進要因としては、診断技術の進歩、がん検診・治療に対する一般市民の意識の高まり、ヘルスケア予算の増加などが挙げられます。課題としては、規制上のハードル、高価な診断方法、地域によっては特定の技術が不足していることなどが挙げられます。

頭頸部がん診断市場の促進要因は以下の通りです:

  • 技術の進歩:診断サービス市場は、確立された検査と新たに登場した分子ベースの検査の両方における継続的な進歩によって進化しています。これらの開発により、頭頸部がんの診断の効率とタイミングが改善され、診断手技の需要増につながっています。
  • がん教育の範囲の拡大:公衆衛生キャンペーンにより、頭頸部がんを含むがんの早期発見に対する意識が高まっています。これにより、検診や診断を受ける人が増えています。
  • ヘルスケア支出の増加:新興市場ではヘルスケア支出が増加しており、診断ツールへの投資が可能になっています。これらの市場のヘルスケア機関は新しい診断機器を導入し、質の高いヘルスケアへのアクセスを向上させ、市場の成長を促進しています。
  • 高齢者人口の増加:高齢化は頭頸部がんの有病率上昇に寄与しています。高齢者人口の増加に伴い、診断サービスに対する需要が増加し、市場成長のさらなる原動力となっています。
  • 標的治療プログラム:より多くの標的療法が開発されるにつれて、これらの療法に適合する高度な診断ツールの需要が増加しています。患者固有の健康状態に基づいてがんを診断することで、オーダーメイドの診断ツールの必要性が高まります。

頭頸部がん診断市場における課題は以下の通りです:

  • 高価な先進的診断ツール:新しい診断機器は高価であることが多く、資源の乏しい地域では使用が制限されます。その結果、診断や治療が遅れ、回復が遅れる可能性があります。
  • 規制遵守に伴う課題:診断薬市場における複雑な規制を乗り越えることは、企業にとって大変なことです。様々な基準や法律を遵守することはコストがかかり、新製品の市場参入を遅らせる可能性があります。
  • 先端診断技術へのアクセス制限:多くの地域、特に発展途上諸国では、先端診断技術へのアクセスが限られています。これは早期発見率の低下や医療の質の低下につながる可能性があり、適切な解決策によって対処する必要があります。

頭頸部がん診断市場は、促進要因と課題の両方によって形成されています。利害関係者が成長機会を活用しながら市場ニーズを満たすソリューションを提供するには、これらの要因を理解することが極めて重要です。

目次

第1章 エグゼクティブサマリー

第2章 世界の頭頸部がん診断市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析(2019年~2031年)

  • マクロ経済動向(2019年~2024年)と予測(2025年~2031年)
  • 世界の頭頸部がん診断市場の動向(2019~2024年)と予測(2025~2031年)
  • 世界の頭頸部がん診断市場:タイプ別
    • 喉頭がん
    • 咽頭がん
    • 唾液腺がん
    • 口唇および口腔がん
    • 鼻咽頭がん
    • その他
  • 世界の頭頸部がん診断市場:診断別
    • バイオスコピースクリーニング検査
    • 血液検査
    • 歯科診断
    • 画像診断
    • 内視鏡検査
  • 世界の頭頸部がん診断市場:治療別
    • 化学療法
    • 放射線治療
    • 標的療法
    • 手術
    • その他
  • 世界の頭頸部がん診断市場:最終用途別
    • 病院
    • 外来手術センター
    • 診断センター
    • その他

第4章 市場動向と予測分析:地域別(2019年~2031年)

  • 世界の頭頸部がん診断市場:地域別
  • 北米の頭頸部がん診断市場
  • 欧州の頭頸部がん診断市場
  • アジア太平洋の頭頸部がん診断市場
  • その他地域の頭頸部がん診断市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 世界の頭頸部がん診断市場の成長機会:タイプ別
    • 世界の頭頸部がん診断市場の成長機会:診断別
    • 世界の頭頸部がん診断市場の成長機会:治療別
    • 世界の頭頸部がん診断市場の成長機会:最終用途別¥
    • 世界の頭頸部がん診断市場の成長機会:地域別
  • 世界の頭頸部がん診断市場の新たな動向
  • 戦略分析
    • 新製品開発
    • 世界の頭頸部がん診断市場のキャパシティ拡大
    • 世界の頭頸部がん診断市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 主要企業プロファイル

  • GE Healthcare
  • Philips
  • Siemens Healthineers
  • Merck
  • Eli Lilly
目次

The future of the global head and neck cancer diagnostic market looks promising with opportunities in the hospital, ambulatory surgical center, and diagnostic center markets. The global head and neck cancer diagnostic market is expected to reach an estimated 3.4 billion by 2031 with a CAGR of 7.1% from 2025 to 2031. The major drivers for this market are the increasing prevalence of head and neck cancer, surfing access to healthcare, and growing awareness of the signs and symptoms of head and neck cancer, as well as the importance of early detection.

  • Lucintel forecasts that, within the diagnosis category, imaging is expected to witness the highest growth over the forecast period.
  • Within the end use category, hospitals will remain the largest segment because it has better disease diagnosis capabilities and also has the latest medical equipment and technology, which allows them to provide patients with the best possible care.
  • In terms of regions, North America will remain the largest region during the forecast period due to the presence of a strong healthcare infrastructure, favorable reimbursement policies, high awareness about the disease, and government support for the development of the healthcare sector.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Head and Neck Cancer Diagnostic Market

The head and neck cancer diagnostic market is changing rapidly, and there are trends that will determine its future. These trends involve new ways of diagnosing and managing patients, as well as new treatment options.

  • Liquid Biopsy Development: Head and neck cancers may be diagnosed at an earlier stage when biopsies are not compatible with surgery. Liquid biopsies are becoming an accepted method of non-invasive tumor identification. They evaluate tumor cells in the bloodstream, providing both diagnosis and responses to treatment sooner than otherwise possible. This phenomenon is changing modern oncology by providing real-time information about tumor growth and response to therapy.
  • Artificial Intelligence in Diagnostics: There is a growing trend towards enhancing head and neck cancer diagnostics through artificial intelligence and machine learning. AI algorithms can assist individuals without prior training to review CT or MR imaging studies and analyze clinical data, thus enhancing clinical decision-making. This technology improves accuracy and efficiency in analyzing images, which are often time-consuming.
  • Personalization of Medicine Gaining Momentum: The increasing use of personalized medicine is driving a new trend toward personalized diagnostics and treatment methods. Genetic and molecular profiling helps determine distinct biomarkers for head and neck cancers, enabling targeted treatment that is more effective and less harmful.
  • Telemedicine and Remote Diagnostic Interfaces: The use of telemedicine for diagnosing head and neck cancers is increasing, particularly in rural and underserved areas. Patients can be treated remotely by monitoring their symptoms and providing timely interventions, which alleviates the burden on healthcare facilities. This expansion helps with early diagnosis of cancers.
  • Growing Cooperation between Academia and Industry: The collaboration between research centers and companies is becoming more active, with the goal of improving head and neck cancer diagnosis. These partnerships aim to foster the invention of better diagnostic tools, benefiting both the healthcare sector and the business environment.

Such trends are likely to positively affect the head and neck cancer diagnostic market by spurring new solutions, increasing diagnostic accuracy, and enabling individualized treatment. Shortly, the integration of new technologies and collaborations is expected to improve clinical outcomes and transform cancer care.

Recent Developments in the Head and Neck Cancer Diagnostic Market

The market for head and neck cancer diagnosis has undergone significant changes, leading to improved detection, accuracy, and patient management. Notable changes include technological advancements, regulatory approvals, and research collaborations.

  • Regulatory Approvals for Biomarkers: The recent FDA approvals of new biomarkers for head and neck cancers are promoting the diagnosis of these cancers. These tests are useful not only for tumor identification but also for assessing specific tumor features, aiding in the early administration of appropriate treatments, and improving clinical outcomes.
  • Imaging Technologies Upgrading: Advanced imaging technologies, such as 3D imaging and hybrid PET/CT scans, are now part of routine diagnostic practice, enabling precise diagnosis of head and neck cancers. These technologies improve treatment planning and monitoring for patients with head and neck tumors.
  • Designing Liquid Biopsies: Liquid biopsy test kits have revolutionized the prospects of diagnosing head and neck tumors. They allow for earlier cancer detection and enable treatment response assessments through simple blood tests instead of invasive procedures.
  • The Role of AI in Cancer Diagnosis: The application of artificial intelligence in imaging interpretation is increasing. AI algorithms can process vast amounts of imaging data with high accuracy, spotting tumors and minimizing human error, thus enhancing diagnostic effectiveness.
  • Telehealth Services: Telehealth services are improving access to diagnostic consultations, especially in rural areas. This approach provides efficient care, reducing the need for patients to visit healthcare facilities.

These trends are transforming the head and neck cancer diagnostic market by enhancing diagnostic accuracy, expanding access to cancer treatment, and enabling customized therapies. Over time, technological advancements are expected to further improve patient outcomes.

Strategic Growth Opportunities for Head and Neck Cancer Diagnostic Market

The head and neck cancer diagnostic market offers various growth opportunities across multiple applications. Understanding these opportunities helps stakeholders choose areas for investment and development.

  • Molecular Diagnostics: The growing demand for molecular diagnostic tests offers a significant opportunity in the market. These tests enable early detection and classification of head and neck cancers, providing critical information needed for effective treatment.
  • AI-Enhanced Imaging Solutions: Healthcare professionals require AI-enhanced imaging solutions that improve diagnostic accuracy. These technologies have high potential and can be developed and marketed to enhance diagnostic efficiency and patient management.
  • Liquid Biopsy Applications: Expanding the use of liquid biopsy applications can drive revenue growth. Non-invasive tests for early-stage diagnosis and treatment evaluation are rapidly emerging, benefiting both patients and service providers.
  • Telehealth Integration: The integration of telehealth offers an authentic growth opportunity by providing diagnostic services remotely. Expanding the market for remote diagnostic tools can improve patient care, especially in distant locations.
  • Initiatives for Collaborative Research: Collaboration between academic and clinical research institutions can lead to faster development of marketable diagnostic tools and techniques. These initiatives can help companies become more competitive in the market.

These strategic growth opportunities address emerging gaps in the head and neck cancer diagnostic market, allowing stakeholders to foster innovative solutions that enhance patient management and competitiveness.

Head and Neck Cancer Diagnostic Market Driver and Challenges

The major drivers in the market include advancements in diagnostic technology, increasing public awareness of cancer screening and treatment, and higher healthcare budgets. Challenges include regulatory hurdles, expensive diagnostic methods, and the lack of certain technologies in some regions.

The factors driving the head and neck cancer diagnostic market include:

  • Technological Advancements: The diagnostic services market is evolving with continuous advancements in both established and emerging molecular-based tests. These developments improve the efficiency and timing of head and neck cancer diagnoses, leading to increased demand for diagnostic procedures.
  • Expanding the Scope of Cancer Education: Public health campaigns have increased awareness about the early detection of cancers, including head and neck cancer. This is encouraging more people to undergo screenings and diagnostics.
  • Increasing Healthcare Spending: Emerging markets are increasing healthcare spending, enabling investments in diagnostic tools. Healthcare institutions in these markets are acquiring new diagnostic equipment, improving access to quality healthcare, and facilitating market growth.
  • Geriatric Population: The aging population is contributing to a rise in head and neck cancer prevalence. As the elderly population grows, the demand for diagnostic services increases, further driving market growth.
  • Targeted Therapy Programs: As more targeted therapies are developed, the demand for advanced diagnostic tools that match these therapies is increasing. Diagnosing cancers based on each patient's specific health condition will drive the need for tailored diagnostic tools.

Challenges in the head and neck cancer diagnostic market include:

  • Advanced Diagnostic Tools are Costly: New diagnostic devices are often expensive, limiting their use in resource-poor areas. This can result in delays in diagnosis and treatment, leading to poorer recovery outcomes.
  • Challenges Associated with Regulatory Compliance: Navigating complex regulations in the diagnostic market can be daunting for companies. Compliance with various standards and laws can be costly and delay the market entry of new products.
  • Limited Reach to Advanced Diagnostic Technologies: Access to advanced diagnostic technology is limited in many areas, particularly in developing countries. This can result in lower early detection rates and reduced care quality, which needs to be addressed through relevant solutions.

The head and neck cancer diagnostic market is shaped by both enablers and obstacles. Understanding these factors is crucial for stakeholders to offer solutions that meet market needs while taking advantage of growth opportunities.

List of Head and Neck Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies head and neck cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the head and neck cancer diagnostic companies profiled in this report include-

  • GE Healthcare
  • Philips
  • Siemens Healthineers
  • Merck
  • Eli Lilly

Head and Neck Cancer Diagnostic by Segment

The study includes a forecast for the global head and neck cancer diagnostic market by type, diagnosis, treatment, end use, and region.

Head and Neck Cancer Diagnostic Market by Type [Analysis by Value from 2019 to 2031]:

  • Laryngeal Cancer
  • Pharyngeal Cancer
  • Salivary Gland Cancer
  • Lip & Oral Cavity Cancer
  • Nasopharyngeal Cancer
  • Others

Head and Neck Cancer Diagnostic Market by Diagnosis [Analysis by Value from 2019 to 2031]:

  • Bioscopy Screening Tests
  • Blood Tests
  • Dental Diagnosis
  • Imaging
  • Endoscopy

Head and Neck Cancer Diagnostic Market by Treatment [Analysis by Value from 2019 to 2031]:

  • Chemotherapy
  • Radiation Therapy
  • Targeted Therapy
  • Surgery
  • Others

Head and Neck Cancer Diagnostic Market by End Use [Analysis by Value from 2019 to 2031]:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others

Head and Neck Cancer Diagnostic Market by Region [Analysis by Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Head and Neck Cancer Diagnostic Market

The head and neck cancer diagnostic market is making significant progress due to technological advancements, rising demand for cancer diagnosis, and increased awareness about early detection. The United States, China, Germany, India, and Japan are investing in R&D to advance diagnostic techniques for head and neck cancer. These developments aim to improve healthcare quality by enhancing diagnostic accuracy, reducing costs, and enabling timely action.

  • United States: Advances in molecular diagnosis and liquid biopsy strategies are revolutionizing the diagnosis of head and neck cancer. The development of targeted therapies and improvements in diagnostic imaging technologies, such as artificial intelligence, are also enhancing diagnostic accuracy and efficiency.
  • China: China's growing healthcare investment is driving innovations in cancer diagnosis, particularly for head and neck cancers. New imaging devices, such as advanced CT scanners, are being adopted, and there is a strong focus on the development of genetic testing kits for screening cancer susceptibility.
  • Germany: Germany is making significant strides in creating accurate diagnostic tools for head and neck cancers. New research emphasizes the use of directed imaging radionics to increase sensitivity to early tumor changes, while collaborative efforts between universities and healthcare companies are developing innovative biopsy techniques.
  • India: Efforts in India are focused on improving the accessibility of head and neck cancer diagnostic services, especially in rural areas. Initiatives such as telemedicine and mobile health services aim to improve access, while cost-effective diagnostic studies are being conducted to create affordable screening tests.
  • Japan: Japan is at the forefront of head and neck cancer management, with advanced imaging systems incorporated into diagnostic practices. Combined imaging modalities like PET-CT are improving diagnostic efficacy, while targeted therapy development based on cancer genomics is enhancing personalized medicine in the country.

Features of the Global Head and Neck Cancer Diagnostic Market

Market Size Estimates: Head and neck cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Head and neck cancer diagnostic market size by various segments, such as by type, diagnosis, treatment, end use, and region in terms of ($B).

Regional Analysis: Head and neck cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, diagnosis, treatments, end uses, and regions for the head and neck cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the head and neck cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the head and neck cancer diagnostic market by type (laryngeal cancer, pharyngeal cancer, salivary gland cancer, lip & oral cavity cancer, nasopharyngeal cancer, and others), diagnosis (bioscopy screening tests, blood tests, dental diagnosis, imaging, and endoscopy), treatment (chemotherapy, radiation therapy, targeted therapy, surgery, and others), end use (hospitals, ambulatory surgical centers, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Head and Neck Cancer Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Head and Neck Cancer Diagnostic Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Head and Neck Cancer Diagnostic Market by Type
    • 3.3.1: Laryngeal Cancer
    • 3.3.2: Pharyngeal Cancer
    • 3.3.3: Salivary Gland Cancer
    • 3.3.4: Lip & Oral Cavity Cancer
    • 3.3.5: Nasopharyngeal Cancer
    • 3.3.6: Others
  • 3.4: Global Head and Neck Cancer Diagnostic Market by Diagnosis
    • 3.4.1: Bioscopy Screening Tests
    • 3.4.2: Blood Tests
    • 3.4.3: Dental Diagnosis
    • 3.4.4: Imaging
    • 3.4.5: Endoscopy
  • 3.5: Global Head and Neck Cancer Diagnostic Market by Treatment
    • 3.5.1: Chemotherapy
    • 3.5.2: Radiation Therapy
    • 3.5.3: Targeted Therapy
    • 3.5.4: Surgery
    • 3.5.5: Others
  • 3.6: Global Head and Neck Cancer Diagnostic Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Ambulatory Surgical Centers
    • 3.6.3: Diagnostic Centers
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Head and Neck Cancer Diagnostic Market by Region
  • 4.2: North American Head and Neck Cancer Diagnostic Market
    • 4.2.1: North American Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
    • 4.2.2: North American Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
  • 4.3: European Head and Neck Cancer Diagnostic Market
    • 4.3.1: European Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
    • 4.3.2: European Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
  • 4.4: APAC Head and Neck Cancer Diagnostic Market
    • 4.4.1: APAC Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
    • 4.4.2: APAC Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
  • 4.5: ROW Head and Neck Cancer Diagnostic Market
    • 4.5.1: ROW Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
    • 4.5.2: ROW Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Type
    • 6.1.2: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Diagnosis
    • 6.1.3: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Treatment
    • 6.1.4: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by End Use
    • 6.1.5: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Head and Neck Cancer Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Head and Neck Cancer Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Head and Neck Cancer Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GE Healthcare
  • 7.2: Philips
  • 7.3: Siemens Healthineers
  • 7.4: Merck
  • 7.5: Eli Lilly